The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Humanizing Cybersecurity Through a ‘Safer Shift’
Cybersecurity isn’t just tech. Safer Shift’s Tiziana Barrow shares how storytelling can make digital safety intuitive and human.
24m watch -
Staying Ahead of AI-Driven Cyber Threats
Robert Roser shares insights on emerging cybercrime trends, supply chain risks and how federal organizations can build stronger security through zero trust.
8m watch -
Marine Corps’ Project Dynamis Speeds AI for Future Battlefield Operations
Col. Arlon Smith shares how Project Dynamis is helping the Marine Corps rapidly field AI capabilities and operate in a future dominated by autonomous systems.
5m listen -
CMS Advances Zero Trust, AI Security in IT Modernization Push
The agency is consolidating platforms to improve security and efficiency.
10m watch